Merck ( MRK, Financials) stated that sacituzumab tirumotecan (sac-TMT) was designated a Breakthrough Therapy by the FDA for advanced or metastatic nonsquamous non-small cell lung cancer with epidermal ...

The FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for patients with advanced or metastatic ...

A new method can improve treatment for patients with chronic myeloid leukaemia by predicting which medication will be most effective. The method also works for other forms of cancer where resistance ...

Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...

Merck's (MRK) antibody drug conjugate sac-TMT has received FDA Breakthrough Therapy designation for the treatment of EGFR-mutated lung cancer. Read more here.

Merck (MRK) announced that the U.S. FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for the treatment of patients ...

Revenue generated from pharma research and development services was RMB24.9 million (US$3.5 million) for the three months ...

Discover the pivotal role of extrachromosomal DNA (ecDNA) in cancer biology and its implications for future treatments.

Sharp increases in delivery costs, by as much as 25%1, may have led to reduced Black-Friday profits for ecommerce businesses. nShift, the global leader in multi-carrier delivery management, is ...

Palantir Technologies Inc. today announced that it has been granted FedRAMP High Authorization for Palantir Federal Cloud Service (PFCS) and Palantir Federal Cloud Service - Supporting Services ...

This page includes links to articles highlighting the top lung cancer research published on Cancer Therapy Advisor in 2024.

Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...